Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Hoe 111
2. Hoe-111
3. Hr 111v
4. Hr-111v
1. 84957-30-2
2. Cobactan
3. Cefquinoma
4. Hr111v
5. Z74s078cwp
6. 1-[[(6r,7r)-7-[[(2z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-5,6,7,8-tetrahydro-quinolinium Inner Salt
7. Cefquinome (inn)
8. (6r,7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-3-(5,6,7,8-tetrahydroquinolin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
9. Cefquinome [inn]
10. Cefquinomum
11. Cefquinome [inn:ban]
12. Cefquinomum [inn-latin]
13. Cefquinoma [inn-spanish]
14. Unii-z74s078cwp
15. Cefquinome [mi]
16. Cobactan [veterinary] (tn)
17. Schembl149896
18. Chembl1631107
19. Dtxsid00894103
20. Akos025402360
21. D07652
22. 1-(((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-5,6,7,8-tetrahydroquinolinium Hydroxide, Inner Salt, 7(sup 2)-(z)-(o-methyloxime)
23. 1-(((6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-5,6,7,8-tetrahydroquinolinium Hydroxide, Inner Salt, 72-(z)-(o-methyloxime)
24. Quinolinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-5,6,7,8-tetrahydro-, Hydroxide, Inner Salt, (6r-(6.alpha.,7.beta.(z)))-
Molecular Weight | 528.6 g/mol |
---|---|
Molecular Formula | C23H24N6O5S2 |
XLogP3 | 1.5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 6 |
Exact Mass | 528.12496023 g/mol |
Monoisotopic Mass | 528.12496023 g/mol |
Topological Polar Surface Area | 208 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 971 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
A Cefquinome manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefquinome, including repackagers and relabelers. The FDA regulates Cefquinome manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefquinome API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cefquinome manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cefquinome supplier is an individual or a company that provides Cefquinome active pharmaceutical ingredient (API) or Cefquinome finished formulations upon request. The Cefquinome suppliers may include Cefquinome API manufacturers, exporters, distributors and traders.
click here to find a list of Cefquinome suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Cefquinome Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefquinome GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefquinome GMP manufacturer or Cefquinome GMP API supplier for your needs.
A Cefquinome CoA (Certificate of Analysis) is a formal document that attests to Cefquinome's compliance with Cefquinome specifications and serves as a tool for batch-level quality control.
Cefquinome CoA mostly includes findings from lab analyses of a specific batch. For each Cefquinome CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefquinome may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefquinome EP), Cefquinome JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefquinome USP).
LOOKING FOR A SUPPLIER?